Cognitive / Optical Coherence Tomography (OCT) Study
Only patients with a diagnosis of relapsing, remitting Clinically Definitive Multiple Sclerosis (CDMS) or Clinically Isolated Syndrome will be included in the study. Time since diagnosis optimally within 2 or 3 years.
Subjects should be 18-50 years old, both genders with Clinically Definitive Multiple Sclerosis or Clinically Isolated Syndrome and includes those with abnormal MRI with the following criteria:
- Expanded Disability Status Scale (EDSS) score ranging from 0 to 3.
- Patients with or without a history of optic neuritis (ON) can be included. Patients with a history of ON must have at least one eye that is free of an active episode of ON for at least six months.
- Patients with double vision or nystagmus can be included.
Patients with diagnosed diseases other than MS that affect the central nervous system and/or cognition, as well as those with retinal pathology will be excluded from this study.
- Patients with a history of autoimmune diseases, Alzheimer's, other types od dementia, recent stroke (one year), Parkinson's disease and choreas.
- Patients with advanced glaucoma, proliferative diabetic retinopathy, macular degeneration and retinopathy, retinal detachment.
- Patients already diagnosed with depression or severe cognitive dysfunction will be excluded, as well as those taking psychotropic drugs. The study design includes tests for exclusion of patients from futher testing if they prove to be depressed (a depression scale) or have severe cognitive dysfunction (mini-mental exam).
Please send your patients to:
Dr. Rosa Tang, MD, MPH, MBA
MS Eye Care at The University Eye Institute
4901 Calhoun Rd, UH Entrance 2
Houston, Texas 77204
Call to schedule an appointment or download this form and fax it to us!
(please write MS COGNITIVE OCT under referral reason)